Zepbound is Eli Lilly's brand name for tirzepatide
A minimum weight gain, and no weight loss, is currently recommended for all pregnant women, including those who are already overweight or obese, due to the obligatory weight gain that occurs in maternal tissues during pregnancy with chronic malabsorption syndrome with cholestasis with known hypersensitivity to Orlistat or to any component of this product Warnings and Precautions: Orlistat may interact with concomitant drugs including cyclosporine, levothyroxine, warfarin, amiodarone, antiepileptic drugs, and antiretroviral drugs Orlistat can decrease cyclosporine exposure
Activity Level Adjustments Non-exercise activity thermogenesis (NEAT) contributes significantly to daily energy expenditure and often decreases unconsciously during caloric restriction
Women of childbearing age who are planning to conceive or are pregnant require careful management, as the effects of semaglutide on fertility, pregnancy, and fetal development are not fully understood